SEMA6C encodes an axon guidance factor that may function as a tumor suppressor by inhibiting the AKT/GSK3 signaling pathway, which in turn activates the intrinsic mitochondrial apoptotic event through the PI3K/Akt signaling axis (Hung et al. 2022). The gene discussed is SEMA6C; the disease is neoplasm.